Changeflow GovPing Pharma & Drug Safety Patent Application for Novel Compound Treating ...
Routine Notice Added Draft

Patent Application for Novel Compound Treating Neurodegeneration and Cardiovascular Diseases

Favicon for changeflow.com ChangeBridge: Patent Apps - Organic Chemistry (C07D)
Published September 25th, 2023
Detected March 26th, 2026
Email

Summary

The USPTO has published a patent application (US20260085083A1) for a novel compound and pharmaceutical composition developed by SHANDONG RUZHI BIOMEDICINE TECHNOLOGY CO., LTD. The compound is intended for preventing or treating neurodegenerative diseases and cardiovascular/cerebrovascular diseases.

What changed

This document is a published patent application from the USPTO for a novel compound and pharmaceutical composition. The application, filed by SHANDONG RUZHI BIOMEDICINE TECHNOLOGY CO., LTD, details a compound represented by formula (I) that can be used in medicaments for preventing or treating neurodegenerative diseases and cardiovascular and cerebrovascular diseases. The application number is 19113500, and it was filed on September 25, 2023.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in pharmaceutical research and development. Companies operating in the pharmaceutical and biotechnology sectors should monitor the progress of this patent application and related research for insights into emerging treatments and potential intellectual property considerations.

Source document (simplified)

← USPTO Patent Applications

NOVEL COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

Application US20260085083A1 Kind: A1 Mar 26, 2026

Assignee

SHANDONG RUZHI BIOMEDICINE TECHNOLOGY CO., LTD

Inventors

Zhefeng ZHANG, Yuelei MENG

Abstract

A novel compound, a pharmaceutical composition thereof, and use thereof. The novel compound is represented by formula (I), wherein the details of the definition of each substituent group are shown in the specification. The compound can be used for preparing a medicament for preventing or treating a neurodegeneration disease and a cardiovascular and cerebrovascular disease.

CPC Classifications

C07F 9/6561 A61K 31/235 A61K 31/265 A61K 31/4155 A61K 31/4965 A61K 31/4985 A61K 31/675 A61P 9/00 A61P 25/28 C07B 59/002 C07C 69/76 C07C 69/96 C07D 241/12 C07D 241/24 C07D 405/04 C07D 491/048

Filing Date

2023-09-25

Application No.

19113500

View original document →

Named provisions

Abstract Assignee Inventors

Classification

Agency
USPTO
Published
September 25th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085083A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Pharmaceutical Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Healthcare

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.